Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab vs Methotrexate in Psoriasis (CHAMPION)
NCT00235820Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jul 2005
- Primary completion
- May 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of adalimumab in plaque psoriasis (3 arms), sponsored by Abbott Laboratories. Primary endpoints: Proportion of subjects achieving at least 75% improvement in PASI at 16 weeks and Safety parameters. Started Jul 2005; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00235820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235820.